WHO: Ebola vaccine trials could begin in January
An official for the World Health Organization announced Tuesday that experimental Ebola vaccines — in as many as tens of thousands of doses — could be ready for testing in January.
Assistant Director General for the WHO Dr. Marie Paule Kieny, said that the "real-world" testing could begin after clinical trials in Africa, Europe, and the United States. Data from at least two of the vaccines, one of which is now in clinical trials, is expected by December. Kieny clarified that the volunteers who participate in the vaccines' testing could not contract Ebola from the trials.
The WHO's most recent estimate says that the current Ebola outbreak in West Africa has killed more than 4,500 people, primarily in Liberia, Guinea, and Sierra Leone. The U.N.'s emergency Ebola committee will meet in Geneva later this week to determine additional courses of action for controlling the current outbreak.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Meghan DeMaria is a staff writer at TheWeek.com. She has previously worked for USA Today and Marie Claire.
-
How Tesla has put Elon Musk on track to be the world’s first trillionaireIn The Spotlight The package agreed by the Tesla board outlines several key milestones over a 10-year period
-
Cop30: is the UN climate summit over before it begins?Today’s Big Question Trump administration will not send any high-level representatives, while most nations failed to submit updated plans for cutting greenhouse gas emissions
-
‘The Big Crunch’: why science is divided over the future of the universeThe Explainer New study upends the prevailing theory about dark matter and says it is weakening
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
